![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 49, 46237-46242, December 7, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Institut de Biochimie et Génétique
Cellulaires, CNRS Unité Mixte de Recherche 5095, 1 rue Camille
Saint-Saëns, F-33077 Bordeaux Cedex, France
Mycophenolic acid (MPA), one of the most
promising immunosuppressive drugs recently developed, is a potent
inhibitor of IMP dehydrogenase, the first committed step toward GMP
synthesis. We found that all the drug effects on yeast cells
were prevented by bypassing GMP synthesis, thus confirming the high
specificity of MPA. Although the primary target of MPA is clearly
identified, we aimed to further understand how GTP depletion leads to
growth arrest and developed a new approach based on proteome analysis combined with overexpression studies. Essential proteins down-expressed in the presence of MPA were identified by protein two-dimensional gel
analysis and subsequently overexpressed in yeast. Two such proteins,
Cdc37p and Sup45p, when overexpressed allowed partial relief of MPA
toxicity, strongly suggesting that their lower amount after MPA
treatment significantly contributed to the MPA effect. These conserved
proteins involved in cell cycle progression and translation are
therefore important secondary targets for MPA. Our data establish that
MPA effects occur through inhibition of a unique primary target
resulting in guanine nucleotides depletion, thereby affecting multiple
cellular processes.
To whom correspondence should be addressed. Tel.:
33-5-56-99-90-55; Fax: 33-5-56-99-90-59; E-mail:
B.Daignan-Fornier@ibgc.u-bordeaux2.fr.
This article has been cited by other articles:
![]() |
A. Breton, B. Pinson, F. Coulpier, M.-F. Giraud, A. Dautant, and B. Daignan-Fornier Lethal Accumulation of Guanylic Nucleotides in Saccharomyces cerevisiae HPT1-Deregulated Mutants Genetics, February 1, 2008; 178(2): 815 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. McPhillips, J. W. Hyle, and D. Reines Detection of the mycophenolate-inhibited form of IMP dehydrogenase in vivo PNAS, August 17, 2004; 101(33): 12171 - 12176. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Escobar-Henriques, B. Daignan-Fornier, and M. A. Collart The Critical cis-Acting Element Required for IMD2 Feedback Regulation by GDP Is a TATA Box Located 202 Nucleotides Upstream of the Transcription Start Site Mol. Cell. Biol., September 1, 2003; 23(17): 6267 - 6278. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Hyle, R. J. Shaw, and D. Reines Functional Distinctions between IMP Dehydrogenase Genes in Providing Mycophenolate Resistance and Guanine Prototrophy to Yeast J. Biol. Chem., August 1, 2003; 278(31): 28470 - 28478. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Desmoucelles, B. Pinson, C. Saint-Marc, and B. Daignan-Fornier Screening the Yeast "Disruptome" for Mutants Affecting Resistance to the Immunosuppressive Drug, Mycophenolic Acid J. Biol. Chem., July 19, 2002; 277(30): 27036 - 27044. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |